Methods for cardioprotection and cardioregeneration with dimers of EGF family ligands
作者： Steven M. Jay , Richard T. Lee , Linda G. Griffith
DOI:
关键词:
摘要: The invention provides methods and compositions for reducing, preventing or reversing cardio toxicity side effects associated with certain therapeutic agents. also treating heart dysfunction including failure, the of myocardial infarction. various aspects involve use ligand dimers, such as neuregulin that selectively induce dimerization EGF receptors in cardiac tissue.
lens.org 参考文章(88)
William J. Mcbride, Edmund A. Rossi, Chien Hsing Chang, David M. Goldenberg, Methods for generating bioactive assemblies and uses thereof ,(2006)
Zbigniew Szewczuk, Yasuo Konishi, Yuko Tsuda, Bivalent thrombin inhibitors ,(1994)
A Zaczek, K P Bielawski, B Brandt, The diverse signaling network of EGFR, HER2, HER3 and HER4 tyrosine kinase receptors and the consequences for therapeutic approaches. Histology and Histopathology. ,vol. 20, pp. 1005- 1015 ,(2005) , 10.14670/HH-20.1005
Mark A. Lemmon, Joseph Schlessinger, John E. Ladbury, Irit Lax, Ben Lewis Margolis, Methods for treatment or diagnosis of diseases or conditions associated with abnormal signal transduction ,(1995)
Nita Maihle, Hakjoo Lee, System and method to inhibit heregulin activated processes and other methods using soluble ErbB3 and method to produce soluble ErbB3 ,(2002)
Michael D. Carrithers, Michael Rush Lerner, Bivalent agonists for G-protein coupled receptors ,(1997)
Z Fan, J Mendelsohn, H Masui, R Kumar, Regulation of epidermal growth factor receptor in NIH3T3/HER14 cells by antireceptor monoclonal antibodies. Journal of Biological Chemistry. ,vol. 268, pp. 21073- 21079 ,(1993) , 10.1016/S0021-9258(19)36895-4